DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sabril (Vigabatrin) - Respiratory Distress - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Respiratory Distress (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sabril (Vigabatrin) where reactions include respiratory distress. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Sabril side effects in 9 year old male

Reported by a physician from United States on 2012-08-06

Patient: 9 year old male

Reactions: Pneumonia, Respiratory Distress

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sabril

Other drugs received by patient: Zonisamide; Baclofen



Possible Sabril side effects in 2 year old male

Reported by a consumer/non-health professional from United States on 2012-05-29

Patient: 2 year old male

Reactions: Respiratory Distress

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sabril
    Dosage: 750 mg milligram(s), 2 in 1 d, oral
    Administration route: Oral
    Indication: Grand MAL Convulsion
    Start date: 2011-03-24

Sabril
    Dosage: 750 mg milligram(s), 2 in 1 d, oral
    Administration route: Oral
    Indication: Infantile Spasms
    Start date: 2011-03-24



Possible Sabril side effects in 16 month old female

Reported by a physician from United States on 2012-04-05

Patient: 16 month old female

Reactions: Urinary Tract Infection Bacterial, Respiratory Distress, Enterobacter Test Positive, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sabril
    Dosage: 250 mg milligram(s), am; 500 mg milligram(s), pm
    Indication: Infantile Spasms
    Start date: 2011-08-18
    End date: 2012-03-01

Sabril
    Dosage: 250 mg milligram(s), am; 500 mg milligram(s), pm
    Indication: Infantile Spasms
    Start date: 2012-03-01

Sabril
    Dosage: 250 mg milligram(s), am; 500 mg milligram(s), pm
    Indication: Infantile Spasms
    Start date: 2012-03-01



Possible Sabril side effects in 8 month old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21

Patient: 8 month old female

Reactions: Respiratory Distress

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sabril
    Dosage: 500 mg milligram(s), 2 in 1 d, oral ; 750 mg milligram(s), 2 in 1 d, oral
    Administration route: Oral
    Indication: Infantile Spasms
    Start date: 2011-11-25
    End date: 2011-12-19

Sabril
    Dosage: 500 mg milligram(s), 2 in 1 d, oral ; 750 mg milligram(s), 2 in 1 d, oral
    Administration route: Oral
    Indication: Convulsion
    Start date: 2011-11-25
    End date: 2011-12-19

Sabril
    Dosage: 500 mg milligram(s), 2 in 1 d, oral ; 750 mg milligram(s), 2 in 1 d, oral
    Administration route: Oral
    Indication: Infantile Spasms
    Start date: 2011-12-20

Sabril
    Dosage: 500 mg milligram(s), 2 in 1 d, oral ; 750 mg milligram(s), 2 in 1 d, oral
    Administration route: Oral
    Indication: Convulsion
    Start date: 2011-12-20

Other drugs received by patient: Klonopin; Topamax; Keppra



Possible Sabril side effects in 1 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-09

Patient: 1 year old male

Reactions: Malaise, Respiratory Distress

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sabril



Possible Sabril side effects in 14 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-13

Patient: 14 year old female

Reactions: Urinary Tract Infection, Condition Aggravated, Complex Partial Seizures, Respiratory Distress

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sabril

Other drugs received by patient: Keppra; Topamax; Phenobarbital TAB

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017